T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapy

被引：1
|
作者：
Martin, Lisa J. [1 ]
Whitmore, James B. [1 ]
Shen, Rhine R. [1 ]
Neumann, Frank [1 ]
机构：
[1] Kite A Gilead Co, 2400 Broadway, Santa Monica, CA 90404 USA
来源：
BLOOD ADVANCES | 2024年 / 8卷 / 15期
关键词：
D O I：
10.1182/bloodadvances.2024013248
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4144 / 4148
页数：5
相关论文
共 50 条
  • [31] The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies
    Cao, Jun-Xia
    Gao, Wei-Jian
    You, Jia
    Wu, Li-Hua
    Liu, Jin-Long
    Wang, Zheng-Xu
    CYTOTHERAPY, 2019, 21 (07) : 769 - 781
  • [32] Transfusion Support for CD19 Chimeric Antigen Receptor T-Cell Therapy
    Saifee, Nabiha H.
    Cottrell, Ryan
    Kuciel, Ariel
    Gardner, Rebecca A.
    Delaney, Meghan
    TRANSFUSION, 2019, 59 : 194A - 195A
  • [33] A New Frontier: CD19 Chimeric Antigen Receptor T-Cell Therapy
    Alkureishi, Lolita Alcocer
    Hageman, Joseph R.
    PEDIATRIC ANNALS, 2024, 53 (05): : e157 - e158
  • [34] Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies
    Kobayashi, Eiji
    Kamihara, Yusuke
    Arai, Miho
    Wada, Akinori
    Kikuchi, Shohei
    Hatano, Ryo
    Iwao, Noriaki
    Susukida, Takeshi
    Ozawa, Tatsuhiko
    Adachi, Yuichi
    Kishi, Hiroyuki
    Dang, Nam H.
    Yamada, Taketo
    Hayakawa, Yoshihiro
    Morimoto, Chikao
    Sato, Tsutomu
    CELLS, 2023, 12 (16)
  • [35] Limited utility of chimeric antigen receptor (CAR) T-cell retreatment: experience with a human anti-CD19 CAR
    Jennifer N. Brudno
    James N. Kochenderfer
    Bone Marrow Transplantation, 2023, 58 : 1157 - 1159
  • [36] Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis
    Anagnostou, Theodora
    Riaz, Irbaz B.
    Hashmi, Shahrukh K.
    Murad, Mohammad H.
    Kenderian, Saad S.
    LANCET HAEMATOLOGY, 2020, 7 (11): : E816 - E826
  • [37] Gene expression signatures of response to anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in patients with CLL and ALL
    Orlando, Elena
    Leary, Rebecca
    Lacey, Simon F.
    Fraietta, Joseph
    Bedoya, Felipe
    Ambrose, David
    Wilcox, Nicholas
    Maude, Shannon L.
    Frey, Noelle V.
    Levine, Bruce L.
    Grupp, Stephan A.
    Porter, David L.
    Young, Regina
    Winckler, Wendy
    Morrissey, Michael
    June, Carl H.
    Melenhorst, Jan Joseph
    Brogdon, Jennifer
    Bitter, Hans
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [38] Limited utility of chimeric antigen receptor (CAR) T-cell retreatment: experience with a human anti-CD19 CAR
    Brudno, Jennifer N.
    Kochenderfer, James N.
    BONE MARROW TRANSPLANTATION, 2023, 58 (10) : 1157 - 1159
  • [39] Cardiotoxicities of Chimeric Antigen Receptor T-Cell Therapy and Bispecific T-Cell Antibodies
    Qamer, Syed Zyad
    Miraglia, Genie M.
    Granville, Matthew J.
    Finkelstein, Alexa
    Okin, Emily
    Mahmood, Syed Saad
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2024, 26 (07) : 175 - 187
  • [40] Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
    Oh, Bernice L. Z.
    Vinanica, Natasha
    Wong, Desmond M. H.
    Campana, Dario
    HAEMATOLOGICA, 2024, 109 (06) : 1677 - 1688
12345